chartexchange

Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close

GlobeNewswire Inc. | Oct 9, 2026 4:01 PM EDT

Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization

Read original article